Neurexins are cell-surface molecules that bind neuroligins to form a heterophilic, Ca 2؉ -dependent complex at central synapses. This transsynaptic complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. In addition, both molecules have been identified as candidate genes for autism. Here we performed mutagenesis experiments to probe for essential components of the neurexin/neuroligin binding interface at the single-amino acid level. We found that in neurexins the contact area is sharply delineated and consists of hydrophobic residues of the LNS domain that surround a Ca 2؉ binding pocket. Point mutations that changed electrostatic and shape properties leave Ca 2؉ coordination intact but completely inhibit neuroligin binding, whereas alternative splicing in ␣-and -neurexins and in neuroligins has a weaker effect on complex formation. In neuroligins, the contact area appears less distinct because exchange of a more distant aspartate completely abolished binding to neurexin but many mutations of predicted interface residues had no strong effect on binding. Together with calculations of energy terms for presumed interface hot spots that complement and extend our mutagenesis and recent crystal structure data, this study presents a comprehensive structural basis for the complex formation of neurexins and neuroligins and their transsynaptic signaling between neurons.calcium ͉ cell adhesion ͉ LNS domain ͉ neurotransmission ͉ synaptogenesis T he heterophilic complex formed by cell adhesion molecules neurexin (Nrxn) and neuroligin (Nlgn) reflects the asymmetric nature of the synapse with presynaptic and postsynaptic specializations (1, 2). Nrxns and Nlgns are essential molecules because they perform important functions in synaptic transmission (3, 4) and differentiation of synaptic contacts (5, 6), and both molecules have been identified as candidate genes for autism (7,8).Nrxns form a family of transmembrane proteins with variable extracellular sequences. Nrxn genes (Nrxn1-3) give rise to ␣-neurexins and shorter -neurexins that contain five (␣-Nrxn) or two (-Nrxn) splice sites (SS1-5) (9). Although they share most sequences, the essential role of ␣-Nrxn in neurotransmission cannot be replaced by -Nrxn (10), and one ligand exists for ␣-Nrxn that does not bind to -Nrxn (11). In contrast, Nlgn was discovered by its interaction with -Nrxn (12). The cholinesterase-like adhesion molecule (CAM) domain of Nlgn interacts with the extracellular domain of -Nrxn in a Ca 2ϩ -dependent manner, and binding is facilitated by the splice variation of -Nrxn that lacks an insert in SS4 (13). Nlgn mRNA is also susceptible to splicing, at two positions referred to as A and B (12), including splice variants with no insert in B that bind to all -Nrxns and presumably ␣-Nrxn (14). Therefore, the Nrxn/Nlgn complex involves a domain shared by ␣-and -Nrxns, and any structural characterization needs to account for the Ca 2ϩ dependence and regulation by alternative splicing (15-17).Extracell...